Kahn HJ - Search Results

1

Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma.

Purdue MP, From L, Kahn HJ, Armstrong BK, Kricker A, Gallagher RP, McLaughlin JR, Klar NS, Marrett LD. Purdue MP, et al. Among authors: kahn hj. Int J Cancer. 2005 Nov 10;117(3):486-93. doi: 10.1002/ijc.21196. Int J Cancer. 2005. PMID: 15900597

2

Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium.

Niakosari F, Kahn HJ, Marks A, From L. Niakosari F, et al. Among authors: kahn hj. Arch Dermatol. 2005 Apr;141(4):440-4. doi: 10.1001/archderm.141.4.440. Arch Dermatol. 2005. PMID: 15837861

3

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L. Niakosari F, et al. Among authors: kahn hj. Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462. Arch Dermatol. 2008. PMID: 18427039

4

A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.

Burger AM, Gao Y, Amemiya Y, Kahn HJ, Kitching R, Yang Y, Sun P, Narod SA, Hanna WM, Seth AK. Burger AM, et al. Among authors: kahn hj. Cancer Res. 2005 Nov 15;65(22):10401-12. doi: 10.1158/0008-5472.CAN-05-2103. Cancer Res. 2005. PMID: 16288031

5

Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage.

Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A. Kahn HJ, et al. Breast Cancer Res Treat. 2004 Aug;86(3):237-47. doi: 10.1023/B:BREA.0000036897.92513.72. Breast Cancer Res Treat. 2004. PMID: 15567940

6

Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.

Wong NS, Kahn HJ, Zhang L, Oldfield S, Yang LY, Marks A, Trudeau ME. Wong NS, et al. Among authors: kahn hj. Breast Cancer Res Treat. 2006 Sep;99(1):63-9. doi: 10.1007/s10549-006-9181-4. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541316

7

Breast cancer metastasis in a human bone NOD/SCID mouse model.

Yang W, Lam P, Kitching R, Kahn HJ, Yee A, Aubin JE, Seth A. Yang W, et al. Among authors: kahn hj. Cancer Biol Ther. 2007 Aug;6(8):1289-94. doi: 10.4161/cbt.6.8.4504. Epub 2007 May 25. Cancer Biol Ther. 2007. PMID: 17704641 Free article.

8

Prognostic factors affecting the natural history of node-negative breast cancer.

Trudeau ME, Pritchard KI, Chapman JA, Hanna WM, Kahn HJ, Murray D, Sawka CA, Mobbs BG, Andrulis I, McCready DR, Lickley HL. Trudeau ME, et al. Among authors: kahn hj. Breast Cancer Res Treat. 2005 Jan;89(1):35-45. doi: 10.1007/s10549-004-1368-y. Breast Cancer Res Treat. 2005. PMID: 15666195

9

A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors.

Kahn HJ, Marks A. Kahn HJ, et al. Lab Invest. 2002 Sep;82(9):1255-7. doi: 10.1097/01.lab.0000028824.03032.ab. Lab Invest. 2002. PMID: 12218087 Free article. No abstract available.

10

Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients.

Parissenti AM, Chapman JA, Kahn HJ, Guo B, Han L, O'Brien P, Clemons MP, Jong R, Dent R, Fitzgerald B, Pritchard KI, Shepherd LE, Trudeau ME. Parissenti AM, et al. Among authors: kahn hj. Breast Cancer Res Treat. 2010 Jan;119(2):347-56. doi: 10.1007/s10549-009-0531-x. Breast Cancer Res Treat. 2010. PMID: 19771508 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters